NEW YORK (GenomeWeb News) – Bayer today said that its Bayer HealthCare business has joined the non-profit Structural Genomics Consortium.

Bayer will provide funding to the consortium to accelerate drug research in the areas of protein science and epigenetics. In addition, it will collaborate with the consortium on research projects to identify small molecules that can interfere with protein activity involved in epigenetic control. Bayer also said that ti will provide a subset of its compound library to the SGC for screening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.